17 September 2019 – Race Oncology Limited (ASX: RAC) is pleased to announce that prominent biotechnology…
22
Dec
Related Posts
Dr Daniel Tillett joins Race Board
CSO Dr Daniel Tillett talks to Proactive about recent kidney cancer resultshttps://youtu.be/emTcVWAK-UQ
Race appoints Dr Daniel Tillett Chief Scientific OfficerRace Oncology is pleased to announce that Dr Daniel Tillett has been appointed Chief Scientific…
